Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

EPDS and MS might share an immune-related cause.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Warming hands improves blood flow in people with systemic sclerosis.

Ocrelizumab may cause delayed hair loss in some patients.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Severe allergic reactions to hair dye can trigger hair loss and may be linked to multiple sclerosis.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

4-aminopyridine helps skin wounds heal faster and better.

The document covers various dermatological conditions and their studies.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

CBD is effective for certain epilepsy conditions, shows promise for other health issues, but needs more research for safety and effectiveness.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.